Obesity is known to be a major risk factor that exacerbates metabolic disorders, such as type 2 diabetes. A key molecule involved in this process is endotrophin, a signaling protein that links excess fat accumulation to metabolic decline. Recent research from UNIST has identified a natural compound capable of directly inhibiting endotrophin production, paving the way for innovative therapeutic interventions.
This article was originally published on MedicalXpress.com

